In order to assess the safety of breastfed infants after their mother's postpartum immunization with a combined measles-mumps-rubella (MMR) vaccine, the purpose of this study is to investigate whether measles vaccine strain is excreted in breast milk of breastfeeding women with negative rubella and measles serologies.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Prevalence of the measles vaccine virus strain in breast milk.
Timeframe: day 7 after the first vaccination.
Prevalence of the measles vaccine virus strain in breast milk.
Timeframe: day 11 after the first vaccination.
Prevalence of the measles vaccine virus strain in breast milk.
Timeframe: day 14 after the first vaccination.